Treace John T. - 10 Jan 2024 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Executive Offer, Director, 10%+ Owner
Signature
/s/ Lisa O. Taylor as Attorney in fact for John T. Treace
Issuer symbol
TMCI
Transactions as of
10 Jan 2024
Net transactions value
$0
Form type
4
Filing time
12 Jan 2024, 21:00:14 UTC
Previous filing
10 Mar 2023
Next filing
12 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Award $0 +178,325 +3.2% $0.000000 5,800,180 10 Jan 2024 Direct F1, F2
holding TMCI Common Stock 1,605,000 10 Jan 2024 By Spouse F3
holding TMCI Common Stock 1,471,250 10 Jan 2024 By Spouse as cotrustee of a trust F3
holding TMCI Common Stock 1,839,063 10 Jan 2024 As Trustee of a trust F4
holding TMCI Common Stock 408,816 10 Jan 2024 As Co-Trustee of a trust F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 with the last installment vesting on January 10, 2028; subject to Reporting Person's providing continued service to Issuer through each vesting date.
F2 Includes 203,731 restricted stock units.
F3 The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
F4 The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.